KEGG   DRUG: Talimogene laherparepvecHelp
Entry
D09966                      Drug                                   

Name
Talimogene laherparepvec (USAN);
Talminogene laherparepvec;
Imlygic (TN);
Oncovex (TN)
Product
Remark
ATC code: L01XX51
Product: D09966<US>
Efficacy
Antineoplastic
  Disease
Melanoma [DS:H00038]
Comment
gene therapy drug (oncolytic HSV1, GM-CSF [HSA:1437] [KO:K05427])
Oncolytic virus
Brite
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
 L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
  L01 ANTINEOPLASTIC AGENTS
   L01X OTHER ANTINEOPLASTIC AGENTS
    L01XX Other antineoplastic agents
     L01XX51 Talimogene laherparepvec
      D09966  Talimogene laherparepvec (USAN) <US>
New drug approvals in Europe [br08329.html]
 European public assessment reports (EPAR) authorised medicine
  D09966
BRITE hierarchy
Other DBs
CAS: 1187560-31-1
PubChem: 124490634
LinkDB All DBs

» Japanese version   » Back

DBGET integrated database retrieval system